Antibody-dependent enhancement
Antibody-dependent enhancement[edit | edit source]
Antibody-dependent enhancement[edit | edit source]
Antibody-dependent enhancement (ADE) is a phenomenon in which the presence of specific antibodies enhances the entry of a virus into host cells and its subsequent replication. This process can lead to increased severity of viral infections and is a significant concern in the development of vaccines and therapeutic antibodies.
Mechanism[edit | edit source]
ADE occurs when non-neutralizing or sub-neutralizing antibodies bind to viral particles. Instead of neutralizing the virus, these antibodies facilitate viral entry into host cells via Fc receptors or complement receptors. The virus-antibody complex binds to these receptors on the surface of immune cells, such as macrophages and dendritic cells, leading to increased viral uptake and replication.
The process of ADE is particularly well-documented in flavivirus infections, such as dengue virus. In dengue, individuals who have been previously infected with one serotype of the virus may develop more severe disease upon infection with a different serotype, due to ADE.
Clinical Implications[edit | edit source]
ADE has significant implications for vaccine development. Vaccines that elicit antibodies capable of enhancing viral infection rather than neutralizing it can potentially worsen the disease. This has been a concern in the development of vaccines for viruses such as dengue virus, Zika virus, and coronaviruses, including SARS-CoV-2.
In the case of dengue, the phenomenon of ADE has been linked to the occurrence of dengue hemorrhagic fever and dengue shock syndrome, which are severe forms of the disease. The risk of ADE necessitates careful evaluation of vaccine candidates to ensure that they do not predispose individuals to enhanced disease.
Examples[edit | edit source]
- Dengue Virus: ADE is a well-known mechanism in dengue virus infections. Individuals with antibodies from a previous infection with one serotype can experience more severe disease upon infection with a different serotype.
- Coronavirus: Concerns about ADE have been raised in the context of COVID-19 and the development of SARS-CoV-2 vaccines. However, extensive testing and monitoring are conducted to ensure vaccine safety.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
